CDC Clinical Guidelines on the Use of Doxycycline Postexposure Prophylaxis for Bacterial Sexually Transmitted Infection Prevention, United States, 2024
On June 4, 2024, the CDC released the first national guidelines for doxycycline post-exposure prophylaxis (doxy PEP). The CDC recommendations are for clinicians to: (1) provide counseling about the risks and benefits of doxy PEP to men who have sex with men (MSM) and transgender women (TGW) who have had a bacterial STI (syphilis, chlamydia, or gonorrhea) in the last 12 months, (2) engage in shared decision making, and then (3) offer doxy PEP following that conversation (200 mg, taken within 72 hours after sex). Full Access: CDC
Whooping Cough Cases on the Rise, nearly 3 Times as High as Last Year: CDC
There have been at least 4,864 whooping cough cases reported this year, which is up from the 1,746 cases reported through the same week in 2023, according to the CDC. This is nearly three times higher than cases reported at the same time last year. The number of cases for 2024 is similar to those seen in 2018-2019, before the COVID-19 pandemic. Full Access: CDC
Firearm Storage Behaviors — Behavioral Risk Factor Surveillance System, Eight States, 2021–2022
Among eight states with available data, 18.4%–50.6% of Behavioral Risk Factor Surveillance System respondents reported keeping a firearm in or around the home. Secure firearm storage is associated with lower risk for firearm injuries. Data on state and demographic variation in storage practices might help guide the development and implementation of prevention and evaluation efforts. Full Access: CDC
Pediatric Respiratory Syncytial Virus Hospitalizations and Respiratory Support After the COVID-19 Pandemic
In this cross-sectional study of 288,816 children 5 years or younger from 48 U.S. pediatric hospitals, researcher discuss the surge in RSV infections during the 2022 to 2023 post-pandemic season with a 70% increase in children requiring advanced respiratory support. Children requiring respiratory support during the surge were older and had fewer comorbidities than in pre-pandemic seasons. These findings highlight post-pandemic trends in advanced respiratory support use for pediatric RSV infections that can help inform guidelines as new RSV vaccines become more widely available. Full Access: JAMA
